Learn more

RIBOSCIENCE LLC

Overview
  • Total Patents
    138
  • GoodIP Patent Rank
    13,067
  • Filing trend
    ⇧ 42.0%
About

RIBOSCIENCE LLC has a total of 138 patent applications. It increased the IP activity by 42.0%. Its first patent ever was published in 2002. It filed its patents most often in United States, Australia and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are INST OF ORGANIC CHEMISTRY AND BIOCHEMISTRY ASCR V V I, ATEA PHARMACEUTICALS INC and IDENIX PHARMACEUTICALS LLC.

Patent filings per year

Chart showing RIBOSCIENCE LLCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Smith Mark 100
#2 Klumpp Klaus G 90
#3 Zhang Zhuming 21
#4 Zhang Jing 19
#5 Talamas Francisco Xavier 11
#6 Mark Smith 10
#7 Klaus G Klumpp 5
#8 Martin Joseph Armstrong 5
#9 Klumpp Klaus 5
#10 Sarma Keshab 4

Latest patents

Publication Filing date Title
WO2020210649A1 Bicyclic heteroaryl derivatives as ectonucleotide pyrophosphatase phosphodiesterase 1 inhibitors
WO2020140001A1 Quinazoline derivatives as ectonucleotide pyrophosphatase phosphodiesterase 1 inhibitors
KR20200056420A 4'-fluoro-2'-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication
US2018200280A1 4'-Fluoro-2'-Methyl Substituted Nucleoside Derivatives as Inhibitors of HCV RNA Replication
WO2017142984A1 Inhibitors of zika virus
WO2016115222A1 4'-azido substituted nucleoside derivatives as inhibitors of ebola virus rna replication
AU2015320511A1 4'-vinyl substituted nucleoside derivatives as inhibitors of Respiratory Syncytial Virus RNA replication
CA2945693A1 4'-difluoromethyl substituted nucleoside derivatives as inhibitors of influenza rna replication
US2014341847A1 4′-fluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication
CN105307661A 4'-azido, 3'-deoxy-3'-fluoro substituted nucleoside derivatives
RS56101B1 4'-azido-3'-fluoro substituted nucleoside derivatives as inhibitors of hcv rna replication
HUE033727T2 2',4'-difluoro-2'-methyl substituted nucleoside derivatives as inhibitors of hcv rna replication
UA110428C2 4'-azide, 3'-fluoro substituted derivatives of nucleosides as inhibitors of rna replication with hepatitis c
MX2012008443A 4 ' - azido - nucleosides as anti - hcv compunds.
EP1928475A2 Antiviral phosphoramidates of 4'-c-azido-substituted pronucleotides